Characteristics of patients with refractory celiac disease type II and specific pulmonary involvement
| Patient . | Sex . | Age (years) . | Aberrant T cells in digestive sample (%)* . | Extradigestive localization of aberrant T cells . | Aberrant T cells in BAL (%)* . | Clonal TCR-γ rearrangement in the lung . | Site . | Follow-up (months) . | Outcome . |
|---|---|---|---|---|---|---|---|---|---|
| 1 | F | 36 | 60 | Skin, bone marrow, lung | NA | + | BAL, BB | 60 | Died of digestive lymphoma |
| 2 | M | 39 | 65 | Bone marrow, lung | 0.5 | + | BAL | 96 | Alive |
| 3 | F | 60 | 85 | Bone marrow, lung | 1 | – | 72 | Alive | |
| 4 | F | 68 | 60 | Skin, bone marrow, lung | 0.5 | + | BAL | 36 | Died of skin lymphoma |
| 5 | F | 51 | 80 | Bone marrow, lung | 1 | + | BAL, BB | 36 | Alive |
| 6 | F | 57 | 70 | Skin, bone marrow, blood, lung | 74 | + | BAL, BB | 24 | Died of skin lymphoma |
| 7 | F | 31 | 40 | Bone marrow, lung | NA | + | Mediastinal lymph nodes | 28 | Died of digestive lymphoma |
| Patient . | Sex . | Age (years) . | Aberrant T cells in digestive sample (%)* . | Extradigestive localization of aberrant T cells . | Aberrant T cells in BAL (%)* . | Clonal TCR-γ rearrangement in the lung . | Site . | Follow-up (months) . | Outcome . |
|---|---|---|---|---|---|---|---|---|---|
| 1 | F | 36 | 60 | Skin, bone marrow, lung | NA | + | BAL, BB | 60 | Died of digestive lymphoma |
| 2 | M | 39 | 65 | Bone marrow, lung | 0.5 | + | BAL | 96 | Alive |
| 3 | F | 60 | 85 | Bone marrow, lung | 1 | – | 72 | Alive | |
| 4 | F | 68 | 60 | Skin, bone marrow, lung | 0.5 | + | BAL | 36 | Died of skin lymphoma |
| 5 | F | 51 | 80 | Bone marrow, lung | 1 | + | BAL, BB | 36 | Alive |
| 6 | F | 57 | 70 | Skin, bone marrow, blood, lung | 74 | + | BAL, BB | 24 | Died of skin lymphoma |
| 7 | F | 31 | 40 | Bone marrow, lung | NA | + | Mediastinal lymph nodes | 28 | Died of digestive lymphoma |
BB, bronchial biopsy; F, female; M, male; NA, not available.
Percentage of total sample lymphocytes.